Nomura Asset Management International’s Ascendis Pharma A/S ASND Stock Holding History

Nomura Asset Management International’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-556,427	Closed	-$127M	–	1343
2026 Q1	$127M	Buy	556,427 +59,590	+12%	+$13.4M	0.22%	88
2025 Q4	$106M	Buy	+496,837	New	+$103M	0.16%	153

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Nomura Asset Management International's ASND Position: Q2 2026 in Review

Nomura Asset Management International sold out of Ascendis Pharma A/S (ASND) in Q2 2026, closing a stake of 556,427 shares — an estimated $127M sold.

Nomura Asset Management International first reported a position in ASND in Q4 2025 and held it in 2 quarters. The position peaked at $127M in Q1 2026. 310 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Nomura Asset Management International reported no remaining Ascendis Pharma A/S position as of Q2 2026 after selling out during the quarter.
Nomura Asset Management International sold 556,427 Ascendis Pharma A/S shares in Q2 2026, an estimated $127M.
Nomura Asset Management International first reported a position in Ascendis Pharma A/S in Q4 2025 and held it in 2 quarters.
Nomura Asset Management International's Ascendis Pharma A/S position peaked at $127M in Q1 2026.
310 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.